drugset / Trial / NCT07842861
Morphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in TAP Block in Lower Abdominal Surgeries
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aimed to ascertain the safety and efficacy of dexmedetomidine in comparison to morphine as adjuvants to bupivacaine during transversus abdominis plane (TAP) block in postoperative pain management in adult patients undergoing lower abdominal surgery.
Timeline
- Start
- 2025-12-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | — |
| Subject | Morphine | Other / unclassified | 10 mg | — |
| Background | Bupivacaine | Other / unclassified | 0.25 % | — |
Indications
No indication recorded.